Treatment of the P815 murine mastocytoma
β
Brent A. Williams; Andrew P. Makrigiannis; Jonathan Blay; David W. Hoskin
π
Article
π
1997
π
John Wiley and Sons
π
French
β 122 KB
π 2 views
We have investigated the effect of pre-treatment with the anti-cancer drugs cisplatin and etoposide on the susceptibility of P815 murine mastocytoma cells to lysis by murine spleen-derived anti-CD3-activated killer-T (AK-T) cells. A 20 hr pre-treatment with cisplatin (0.2-2 microg/ml) or etoposide (